Company profile for MetrioPharm

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

MetrioPharm AG is a pharmaceutical development company focusing on therapies for chronic inflammatory diseases. We are developing a new class of self-regulating drugs against cellular oxidative stress. Oxidative stress is one of the central causes of chronic inflammation, triggering a variety of diseases such as arthritis, dementia, cardiovascular disease and other degenerative age-related indications. MetrioPharm AGs develop...
MetrioPharm AG is a pharmaceutical development company focusing on therapies for chronic inflammatory diseases. We are developing a new class of self-regulating drugs against cellular oxidative stress. Oxidative stress is one of the central causes of chronic inflammation, triggering a variety of diseases such as arthritis, dementia, cardiovascular disease and other degenerative age-related indications. MetrioPharm AGs development strategy is aimed specifically at these age-related inflammatory conditions. Our lead compound MP1032 is in Phase II clinical development and has demonstrated therapeutic efficacy and an exceptional.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Bleicherweg 10 8002 Zurich
Telephone
Telephone
+41 44 562 03 35
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
MYR finance chief Christély takes the helm at MetrioPharm
MYR finance chief Christély takes the helm at MetrioPharm

20 Aug 2021

// Kyle LaHucik FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/ex-myr-finance-chief-joins-covid-19-antiviral-chronic-inflammatory-pharma-metriopharm-as

Kyle LaHucik FIERCEBIOTECH
20 Aug 2021

https://www.globenewswire.com/news-release/2021/08/19/2283318/0/en/Thomas-Christ%C3%A9ly-Joins-Management-of-MetrioPharm-AG-as-CEO.html

GLOBENEWSWIRE
19 Aug 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty